KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Asset Writedowns and Impairment (2018 - 2024)

AbbVie has reported Asset Writedowns and Impairment over the past 4 years, most recently at $4.5 billion for Q4 2024.

  • Quarterly Asset Writedowns and Impairment rose 218.58% to $4.5 billion in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $4.5 billion through Dec 2025, changed 0.0% year-over-year, with the annual reading at $847.0 million for FY2025, 81.08% down from the prior year.
  • Asset Writedowns and Impairment was $4.5 billion for Q4 2024 at AbbVie, up from $1.4 billion in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $4.5 billion in Q4 2024 and troughed at $80.0 million in Q2 2023.
  • The 3-year median for Asset Writedowns and Impairment is $1.1 billion (2022), against an average of $1.6 billion.
  • Year-over-year, Asset Writedowns and Impairment soared 174.55% in 2023 and then skyrocketed 218.58% in 2024.
  • A 3-year view of Asset Writedowns and Impairment shows it stood at $770.0 million in 2022, then surged by 82.47% to $1.4 billion in 2023, then skyrocketed by 218.58% to $4.5 billion in 2024.
  • Per Business Quant, the three most recent readings for ABBV's Asset Writedowns and Impairment are $4.5 billion (Q4 2024), $1.4 billion (Q4 2023), and $2.1 billion (Q3 2023).